CCT196969

CCT196969
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T4133-2mg 2 mg

7 - 10 business days*

31.00€
TGM-T4133-5mg 5 mg

7 - 10 business days*

48.00€
TGM-T4133-1mL 1 ml

7 - 10 business days*

55.00€
TGM-T4133-10mg 10 mg

7 - 10 business days*

77.00€
TGM-T4133-25mg 25 mg

7 - 10 business days*

161.00€
TGM-T4133-50mg 50 mg

7 - 10 business days*

261.00€
TGM-T4133-100mg 100 mg

7 - 10 business days*

427.00€
 
Description: CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. It... more
Product information "CCT196969"
Description: CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. It also inhibits SRC, LCK, and the p38 MAPKs. Target: Src, Raf. Smiles: CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(n1)-c1ccccc1. References: Girotti MR,etal.Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma.Cancer Cell. 2015 Jan 12,27(1):85-96.
Supplier: TargetMol
Supplier-Nr: T4133

Properties

Application: Multi-kinase inhibitor
MW: 513.52 D
Formula: C27H24FN7O3

Database Information

CAS : 1163719-56-9| Matching products
KEGG ID : K04366 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "CCT196969"
Write a review
or to review a product.
Viewed